斯塔爾外科公司
US ˙ NasdaqGM ˙ US8523123052

SecuritySTAA / STAAR Surgical Company
InsiderWarren Foust
This page shows the track record and history of Foust Warren insider trades in STAAR Surgical Company. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Warren Foust in STAA / STAAR Surgical Company. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STAA / STAAR Surgical Company Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Warren Foust in STAA / STAAR Surgical Company. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STAA / STAAR Surgical Company Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-19 2026-05-15 4 Foust Warren STAA Common Stock F - Taxes D 32.0700 -1,865 -60 83,112
2026-05-19 2026-05-15 4 Foust Warren STAA Common Stock A - Award D 3,666 84,987
2026-05-19 2026-05-15 4 Foust Warren STAA Common Stock F - Taxes D 32.0700 -3,730 -120 81,321
2026-05-19 2026-05-15 4 Foust Warren STAA Common Stock A - Award D 7,331 85,051
2026-05-19 2026-05-15 4 Foust Warren STAA Common Stock F - Taxes D 32.0700 -3,730 -120 77,720
2026-05-19 2026-05-15 4 Foust Warren STAA Common Stock A - Award D 7,331 81,450
2026-05-19 2026-05-15 4 Foust Warren STAA Common Stock F - Taxes D 32.0700 -7,460 -239 74,119
2026-05-19 2026-05-15 4 Foust Warren STAA Common Stock A - Award D 14,662 81,579
2026-05-12 2026-05-08 4 Foust Warren STAA Common Stock F - Taxes D 26.6900 -3,448 -92 66,917
2026-03-16 2026-03-14 4 Foust Warren STAA Common Stock M - Exercise D 9,775 63,588
2026-03-16 2026-03-14 4 Foust Warren STAA Common Stock M - Exercise D 19,550 53,813
2026-03-16 2026-03-12 4 Foust Warren STAA Common Stock M - Exercise D 8,175 34,263
2025-03-14 2025-03-12 4 Foust Warren STAA Common Stock M - Exercise D 8,175 26,088
2024-05-09 2024-05-08 4 Foust Warren STAA Common Stock F - Taxes D 41.0200 -2,418 -99 17,913
2023-05-09 2023-05-08 4 Foust Warren STAA Common Stock M - Exercise D 20,331 20,331
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)